InVivo Therapeutics Holdings ROA 2010-2023 | NVIVQ
Current and historical return on assets (ROA) values for InVivo Therapeutics Holdings (NVIVQ) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| InVivo Therapeutics Holdings ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2023-09-30 | $-0.01B | $0.01B | -62.07% |
| 2023-06-30 | $-0.01B | $0.01B | -59.02% |
| 2023-03-31 | $-0.01B | $0.02B | -62.50% |
| 2022-12-31 | $-0.01B | $0.02B | -65.67% |
| 2022-09-30 | $-0.01B | $0.01B | -68.57% |
| 2022-06-30 | $-0.01B | $0.02B | -54.32% |
| 2022-03-31 | $-0.01B | $0.02B | -43.96% |
| 2021-12-31 | $-0.01B | $0.02B | -36.00% |
| 2021-09-30 | $-0.01B | $0.02B | -32.00% |
| 2021-06-30 | $-0.01B | $0.03B | -36.78% |
| 2021-03-31 | $-0.01B | $0.03B | -43.24% |
| 2020-12-31 | $-0.01B | $0.02B | -55.17% |
| 2020-09-30 | $-0.01B | $0.01B | -80.00% |
| 2020-06-30 | $-0.01B | $0.01B | -88.89% |
| 2020-03-31 | $-0.01B | $0.01B | -95.65% |
| 2019-12-31 | $-0.01B | $0.01B | -94.12% |
| 2019-09-30 | $-0.01B | $0.01B | -80.00% |
| 2019-06-30 | $-0.01B | $0.01B | -68.57% |
| 2019-03-31 | $-0.02B | $0.02B | -110.00% |
| 2018-12-31 | $-0.02B | $0.02B | -126.32% |
| 2018-09-30 | $-0.03B | $0.02B | -144.44% |
| 2018-06-30 | $-0.03B | $0.02B | -182.86% |
| 2018-03-31 | $-0.03B | $0.01B | -142.86% |
| 2017-12-31 | $-0.03B | $0.01B | -120.93% |
| 2017-09-30 | $-0.03B | $0.02B | -97.20% |
| 2017-06-30 | $-0.02B | $0.02B | -72.44% |
| 2017-03-31 | $-0.02B | $0.03B | -59.86% |
| 2016-12-31 | $-0.02B | $0.04B | -55.42% |
| 2016-09-30 | $-0.02B | $0.04B | -60.13% |
| 2016-06-30 | $-0.02B | $0.04B | -55.07% |
| 2016-03-31 | $-0.02B | $0.05B | -79.34% |
| 2015-12-31 | $-0.03B | $0.02B | -132.00% |
| 2015-09-30 | $-0.04B | $0.02B | -151.58% |
| 2015-06-30 | $-0.04B | $0.03B | -153.85% |
| 2015-03-31 | $-0.03B | $0.03B | -131.82% |
| 2014-12-31 | $-0.02B | $0.02B | -97.30% |
| 2014-09-30 | $-0.02B | $0.02B | -86.49% |
| 2014-06-30 | $-0.02B | $0.02B | -105.26% |
| 2014-03-31 | $-0.03B | $0.01B | -153.85% |
| 2013-12-31 | $-0.04B | $0.02B | -192.41% |
| 2013-09-30 | $-0.04B | $0.02B | -210.26% |
| 2013-06-30 | $-0.03B | $0.03B | -151.35% |
| 2013-03-31 | $-0.01B | $0.01B | -70.59% |
| 2012-12-31 | $0.00B | $0.02B | 21.33% |
| 2012-09-30 | $-0.02B | $0.02B | -135.38% |
| 2012-06-30 | $-0.03B | $0.02B | -207.69% |
| 2012-03-31 | $-0.03B | $0.02B | -315.79% |
| 2011-12-31 | $-0.03B | $0.01B | -544.00% |
| 2011-09-30 | $-0.01B | $0.01B | -71.43% |
| 2011-06-30 | $-0.01B | $0.01B | -156.52% |
| 2011-03-31 | $-0.01B | $0.01B | -211.76% |
| 2010-12-31 | $-0.01B | $0.01B | -355.56% |
| 2010-09-30 | $0.00B | $0.00B | 0.00% |
| 2010-06-30 | $0.00B | $0.00B | 0.00% |
| 2010-03-31 | $0.00B | $0.00B | 0.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.000B | $0.000B |
| InVivo Therapeutics Holdings Corp. operates as a medical device company focused on utilizing polymers as a platform technology to develop treatments to improve function in individuals paralyzed as a result of traumatic spinal cord injury. The company intends to offer three products, including a biocompatible polymer scaffolding device to treat acute wound SCI; a biocompatible hydrogel for local controlled release of methylprednisolone to treat acute SCI; and a biocompatible polymer scaffolding device seeded with autologous hNSCs to treat acute and chronic SCI. InVivo Therapeutics Holdings Corp. is based in Cambridge, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $233.329B | 28.06 |
| Boston Scientific (BSX) | United States | $153.315B | 38.38 |
| Stryker (SYK) | United States | $149.550B | 31.27 |
| EssilorLuxottica (ESLOY) | France | $129.320B | 0.00 |
| Medtronic (MDT) | Ireland | $113.223B | 16.05 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.710B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.111B | 26.31 |
| ResMed (RMD) | United States | $37.519B | 28.18 |
| GE HealthCare Technologies (GEHC) | United States | $34.854B | 16.55 |
| Agilent Technologies (A) | United States | $34.275B | 22.34 |
| Terumo (TRUMY) | Japan | $25.791B | 33.50 |
| Koninklijke Philips (PHG) | Netherlands | $23.611B | 16.57 |
| Insulet (PODD) | United States | $21.226B | 83.32 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.499B | 11.88 |
| Baxter (BAX) | United States | $15.975B | 11.93 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.209B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.821B | 23.74 |
| Lantheus Holdings (LNTH) | United States | $5.509B | 13.90 |
| Prestige Consumer Healthcare (PBH) | United States | $3.962B | 17.70 |
| Perrigo (PRGO) | Ireland | $3.748B | 9.50 |
| Haemonetics (HAE) | United States | $3.663B | 16.68 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.419B | 28.41 |
| ICU Medical (ICUI) | United States | $3.352B | 24.72 |
| QuidelOrtho (QDEL) | United States | $2.041B | 14.04 |
| LeMaitre Vascular (LMAT) | United States | $1.894B | 42.35 |
| AtriCure (ATRC) | United States | $1.554B | 0.00 |
| Acuren (TIC) | United States | $1.375B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.264B | 12.84 |
| Green Thumb Industries (GTBIF) | United States | $1.169B | 26.29 |
| Neogen (NEOG) | United States | $1.135B | 14.53 |
| Phibro Animal Health (PAHC) | United States | $1.133B | 14.48 |
| BioLife Solutions (BLFS) | United States | $1.081B | 0.00 |
| InMode (INMD) | Israel | $0.961B | 9.69 |
| Kestra Medical Technologies (KMTS) | United States | $0.783B | 0.00 |
| Owens & Minor (OMI) | United States | $0.718B | 5.96 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.675B | 0.00 |
| CeriBell (CBLL) | United States | $0.673B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.551B | 0.00 |
| Valneva SE (VALN) | France | $0.494B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.488B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.458B | 0.00 |
| Surmodics (SRDX) | United States | $0.415B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.359B | 13.21 |
| Quanterix (QTRX) | United States | $0.346B | 0.00 |
| SNDL (SNDL) | Canada | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Cerus (CERS) | United States | $0.298B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.280B | 23.60 |
| ZimVie (ZIMV) | United States | $0.279B | 12.67 |
| Sanuwave Health (SNWV) | United States | $0.271B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.266B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.251B | 74.50 |
| Cresco Labs (CRLBF) | United States | $0.251B | 0.00 |
| Brainsway (BWAY) | Israel | $0.242B | 64.00 |
| Biote (BTMD) | United States | $0.229B | 6.45 |
| OraSure Technologies (OSUR) | United States | $0.229B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.219B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.187B | 15.21 |
| TriSalus Life Sciences (TLSI) | United States | $0.185B | 0.00 |
| Organigram Global (OGI) | Canada | $0.185B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.182B | 0.00 |
| Omeros (OMER) | United States | $0.181B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.150B | 0.00 |
| Exagen (XGN) | United States | $0.148B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.128B | 15.73 |
| Jin Medical (ZJYL) | China | $0.100B | 0.00 |
| Fonar (FONR) | United States | $0.096B | 12.33 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| MacroGenics (MGNX) | United States | $0.087B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.086B | 0.00 |
| Veru (VERU) | United States | $0.086B | 0.00 |
| Zynex (ZYXI) | United States | $0.081B | 0.00 |
| Apyx Medical (APYX) | United States | $0.081B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.077B | 0.00 |
| Agape ATP (ATPC) | $0.069B | 0.00 | |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.063B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.060B | 0.00 |
| ImmuCell (ICCC) | United States | $0.058B | 0.00 |
| Nephros (NEPH) | United States | $0.042B | 56.86 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.81 |
| Safety Shot (SHOT) | United States | $0.030B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.028B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.019B | 0.00 |
| INLIF (INLF) | $0.016B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.011B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |